Additional reporting on how the seroprevalence study in California may have been impacted by methodological challenges. New seroprevalence studies are likely to be unveiled in the coming weeks that will give us truer insight into the prevalence of #covid19 https://t.co/KBLjKS3E8B— Scott Gottlieb, MD (@ScottGottliebMD) April 24, 2020
Woops! Was I wrong to single out Stanford?
New York City’s Department of Health sent an alert to providers advising them against using antibody tests to diagnose prior covid infection or to assess immunity because of low reliability and high rates of false positive results. This is a good regulatory action by the city. pic.twitter.com/2o68NowbtO— Scott Gottlieb, MD (@ScottGottliebMD) April 24, 2020